Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis

Zero hospital admissions for infection after 577 transperineal prostate biopsies using... Introduction Purpose To determine the rate of hospital admissions for infection after transperineal biopsy of prostate (TPB) with Prostate biopsies are essential in the diagnosis of prostate single-dose cephazolin prophylaxis using a prospective cancer and therefore are a common procedure performed database. by urologists [1, 2]. The most frequently used approach to Method Between April 2013 and February 2016, 577 prostate biopsy is via the transrectal route guided by ultra- patients undergoing TPB had 2 g of cephazolin given intra- sound imaging (TRUS biopsy) [2–4]. It is the method of venously at induction of anaesthesia. Data collected from choice amongst many urologists as it can be performed these patients included age, PSA, prostate volume, number quickly under local anaesthesia [5]. However, in recent of cores taken and post-operative complications. years, there have been increasing concerns that this Results No patients were readmitted to hospital with infec- approach is associated with rising rates of infective com- tion post-TPB. Seven patients developed acute urinary plications. Nam et al. [6] reported a fourfold increase in retention, and one patient developed clinical prostatitis that the admissions to hospital for complications from TRUS was treated with oral antibiotics in the community. biopsy comparing the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png World Journal of Urology Springer Journals

Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis

Loading next page...
 
/lp/springer_journal/zero-hospital-admissions-for-infection-after-577-transperineal-XI1bGGO2N0
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2016 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Urology; Nephrology; Oncology
ISSN
0724-4983
eISSN
1433-8726
D.O.I.
10.1007/s00345-016-1985-1
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial